Enzyme Finance

Enzyme Finance receives a B- risk grade (28/100) from Hindenrank, where lower scores indicate lower risk. Moderate risk — one of DeFi's most mature asset management platforms with 8+ years of operation and rigorous audits, balanced by composability risk from external DeFi integrations. Enzyme Finance is one of the oldest on-chain asset management platforms in DeFi, operating since 2017 (originally as Melon Protocol). It enables non-custodial vault creation where managers allocate capital across integrated DeFi protocols with configurable policies and risk controls. With $90M in TVL, 1000+ vaults, and rigorous audit history including PWC audits, its B grade reflects a mature, well-documented design with low mechanism novelty, offset by inherent composability risk from numerous DeFi integrations.

The key risks identified for Enzyme Finance are: (1) Enzyme vaults connect to many external DeFi protocols (Aave, Compound, Uniswap, etc.). A security exploit in any integrated protocol could directly impact Enzyme vaults holding positions in that protocol, though each vault's exposure is limited to the protocols it uses. (2) Vault managers have discretion over investment decisions within their vault's policy constraints. Poor management decisions or manager malfeasance could result in losses for vault depositors, though policy constraints limit the scope of potential abuse. (3) The Enzyme Council, rather than broad token holder governance, controls protocol upgrades. This centralized governance model means a small group has significant authority over infrastructure holding $90M+ in assets. (4) The MLN token has limited price appreciation drivers. Protocol fees are modest relative to MLN's market cap, and the buy-and-burn mechanism may not generate sufficient demand to sustain token value.

Enzyme Finance scores 28/100 across eight risk dimensions: Mechanism Novelty: 0/15, Interaction Severity: 5/20, Oracle Surface: 2/10, Documentation Gaps: 2/10, Track Record: 6/15, Scale Exposure: 3/10, Regulatory Risk: 4/10, Vitality Risk: 6/10. The highest risk area is Vitality Risk at 6/10.

Among 68 rated DeFi protocols on Hindenrank, Enzyme Finance ranks #9 by safety (lowest risk score = safest). Its 28/100 risk score and B- grade place it among the safer DeFi protocols.

Enzyme Finance scores 6/15 on the Track Record risk dimension, indicating some history of security incidents or exploits. Higher scores reflect more severe or frequent incidents. Review the full risk report for details.